May 2026

169 Articles

No Section

eGFR imbalance may confound DOAC-VKA comparisons in kidney transplant recipients

2 March 2026
Author(s): Yifan Jin, Zhicheng Huang, Lijun Zhang, Xin Gan

Dear Editor,

From algorithms to care: ten principles for responsible deployment of artificial intelligence in healthcare

4 February 2026
Author(s): Federico Cabitza, Walter Ricciardi, Gino Gerosa, Gian Franco Gensini, Serafina Valente

Dear Editor,

Clinical Insights

Emerging evidence from combination therapy reinforces the role of β-blockers in resistant hypertension

2 May 2026
Author(s): Stefano Masi, Claudio Borghi

Resistant hypertension (RHTN) represents a growing clinical challenge, affecting an estimated 10–15% of patients with treated hypertension [1–3]. Its prevalence might increase in the coming years,... more

Bedside contrast-enhanced ultrasound: Clinical applications for internal medicine

23 March 2026
Author(s): Andrea Boccatonda, Carla Serra

Point-of-care ultrasound (POCUS) is widely used in Internal Medicine for rapid bedside assessment, but conventional modalities such as B-mode and Doppler provide limited information on tissue... more

It’s time to improve antithrombotic therapy! A global perspective for antithrombotic stewardship

18 March 2026
Author(s): W Ageno, L Bertoletti, E Lindhoff-Last, GYH Lip, K Meijer, M Monreal, H Tran, Y Bessada, D Triller, A Burnett, J Ansell

Antithrombotic stewardship (ATS) is a practical, evidence-based care model slowly gaining traction across the globe [1,2]. The impetus for this trend is the persistent evidence for low-quality... more

Intrinsic capacity in older adults: A concise guide for non-geriatricians

16 March 2026
Author(s): Anna Ronca, Viviana Morgese, Philipe de Souto Barreto, Marco Proietti

Over the past decades, there has been a radical and profound change in the population structure, characterised by a gradual increase in the prevalence of individuals in older age groups and a... more

Commentary

Social determinants of health in the era of precision medicine

6 May 2026
Author(s): Ludovico Furlan, Giorgio Costantino

“Man is by nature a social creature” Aristoteles used to say.

Sustained innovation in ATTR-CM - Twenty years of innovation in transthyretin amyloidosis

30 April 2026
Author(s): Philip N Hawkins

Transthyretin amyloid cardiomyopathy (ATTR-CM) is a progressive disease caused by relentless accumulation of ATTR amyloid in the heart [1]. The past 20 years has seen ATTR-CM evolve from a seemingly... more

Rethinking atrial fibrillation classification: Static labels in a dynamic disease

12 April 2026
Author(s): Koohyar Ahmadzadeh, Amir Askarinejad, Gregory Y.H. Lip

Atrial fibrillation (AF) remains the most common arrhythmia worldwide and a major contributor to mortality and morbidity from stroke and heart failure (HF). Despite growing recognition that AF... more

Integrating multi-omics and artificial intelligence in internal medicine: Opportunities for precision care

12 April 2026
Author(s): Giovanni Santacroce, Antonio Lo Bello, Marietta Iacucci, Antonio Di Sabatino

Modern Internal Medicine stands at a critical inflection point. The traditional disease-centred paradigm, built on clinical phenotypes, organ-based classifications, and population-level evidence, is... more

Expanding the stroke risk paradigm: Left atrial size as a trigger for preventive action

31 March 2026
Author(s): David Pakizer, David Školoudík

Stroke is a vascular disease that impacts the brain and is one of the leading causes of disability and death worldwide; notably, heart diseases contribute significantly to its development and risk.... more

Lungs and heart in COPD exacerbations: it takes two to tango

28 March 2026
Author(s): Bartolome R Celli

The lungs and the heart are inseparably linked anatomically, physiologically, and functionally in their shared task of delivering oxygen to the body and removing the carbon dioxide generated by... more

Left atrial appendage closure for atrial fibrillation stroke prevention in hereditary hemorrhagic telangiectasia is effective and safe with simplified, time-limited antithrombotic therapy

21 March 2026
Author(s): Hanny Al-Samkari

In this issue of the European Journal of Internal Medicine, Torres-Iglesias and colleagues present an observational study of 23 patients with hereditary hemorrhagic telangiectasia (HHT) and atrial... more

The critical role of dietary adherence in secondary cardiovascular prevention: Beyond the nutrient composition

12 March 2026
Author(s): Giovanna Muscogiuri, Annamaria Colao

The management of patients with established coronary heart disease (CHD) has traditionally focused on pharmacological interventions and revascularization procedures. However, lifestyle modifications... more

Can heart failure be detected before it occurs? Insights from circulating microRNAs

5 March 2026
Author(s): Andreea Eunice Cosa, Marta Tajes, Josep Comín-Colet

Heart failure (HF) remains one of the most complex and heterogeneous syndromes in healthcare systems, where multiple biological processes converge long before the onset of symptoms. Despite... more

Corrigendum

Corrigendum to “Role of 12-lead Electrocardiogram for identifying very low mortality risk patients with non-hypotensive acute pulmonary embolism” [European Journal of Internal Medicine 140 (2025) 106373]

5 May 2026
Author(s): Crhistian-Mario Oblitas, Francisco Galeano-Valle, Luis-Antonio Alvarez-Sala Walther, Pablo Demelo-Rodríguez

The authors regret that there is an error in the last row of Table 1, where the wrong information says:

Editorial

When more money does not mean more health- disparities in healthcare efficiency in OECD

25 March 2026
Author(s): Nicolas Garin, Jordi Rello

How to improve the efficiency of the healthcare system is vividly debated, as states facing increased competition for resources struggle to contain healthcare costs. The question is: how do we ensure... more

Hospitalist co-management in multimorbid medical and surgical patients: Insights from the United States and Europe

14 March 2026
Author(s): Ombretta Para, Flora Kisuule, Arántzazu Álvarez-de Arcaya, Antonio Gonzalez Fernandez, Francisco J Rodríguez Gómez, Annette Kurrle, Maximo Bernabeu-Wittel

None.

Ideas and Opinions

Should Ticagrelor in association with aspirin be still considered the standard dual antiplatelet treatment for acute coronary syndromes?

4 May 2026
Author(s): Stefano De Servi, Claudio Montalto, Stefano Savonitto

Ticagrelor, a potent inhibitor of P2Y12 platelet receptor, co-administered with aspirin in dual antiplatelet therapy (DAPT), received marketing authorization from the European Medicines Agency in... more

Internal Medicine Flashcard

Scurvy in a hemodialysis patient after prolonged hospitalization

5 May 2026
Author(s): Naohiro Muraki, Naoto Hamano, Michiya Shinozaki

A 64-year-old woman with a 38-year history of hemodialysis presented with general weakness. Until 3 days before presentation, she had been hospitalized for one month due to bullous pemphigoid... more

The central dot sign in liver

4 May 2026
Author(s): Qingren Cao, Qing Xie, Zhujun Cao

A 24-year-old man presented with a 2-year history of recurrent epistaxis and fatigue. Laboratory workup revealed persistent pancytopenia (white blood cell count 2.23 × 10⁹/L, platelet count 54 × 10⁹/... more

Multiple hepatic lesions and vascular lakes

2 May 2026
Author(s): Monica Rubio-Ardanaz, Miguel Sogbe, Juan Felipe Lucena

An 86-year-old man with a history of polyarteritis nodosa on long-term corticosteroid therapy and prior splenic rupture requiring surgery presented with asthenia, low-grade fever, and jaundice. A CT... more

An unusual case of skin ulcer

22 April 2026
Author(s): A. Poloni, M. Schiavini, A. Giacomelli

A 29-year-old Italian woman presented at the emergency department with a 65-day history of cutaneous lesion on her left forearm, started while she was on a stay in Bolivia. Initially, the lesion was... more

Encephalitis with the temporal lobe signature

11 April 2026
Author(s): Shashikant Saini, Banerjee Bodhibrata, Navneet Sharma

A 16-year-old boy presented with a fever and decreased responsiveness for one day. There was no history of focal neurological deficits or seizures. On examination, he was hemodynamically stable but... more

Painful leg nodules, fever, and ankle arthralgia in a middle-aged woman

3 April 2026
Author(s): Inês Pereira Amaral, Ivânia Soares, Joana Antunes

A previously healthy 56-year-old woman presented with a 2-week history of painful erythematous-to-violaceous firm subcutaneous nodules involving the anterior and posterior aspects of both legs, with... more

A deceptive lung mass in a smoker man

11 March 2026
Author(s): Shashank Kumar, Mahismita Patro, Susama Patra

A 50-year-old man presented with cough, streaky haemoptysis and left-sided chest pain for two weeks. He was a heavy smoker with 30 pack-years of smoking history. Clinical examination showed decreased... more

A woman with fever, feet hypostesia and disseminated papules

9 March 2026
Author(s): Inês Pereira Amaral, Ivânia Soares, Joana Antunes

A previously healthy 75-year-old woman presented with a 3-day history of fever (39.3°C), distal paresthesias and hypoesthesia of both feet, and abrupt onset of disseminated erythematous papules with... more

Tongue atrophy following unexplained nausea, vomiting, and hiccups

26 January 2026
Author(s): Nobuyuki Ishii, Yuma Sato, Miyuki Miyamoto

A 45-year-old woman was admitted with aspiration pneumonia. She was found to have progressive dysphagia and severe dysarthria. Neurological examination showed a hypernasal voice, diminished gag... more

“Normally distended” bladder in an anuric hemodialysis patient

26 January 2026
Author(s): Koji Muro, Noriko Takahara, Haruyoshi Yoshida

A 72-year-old man with end-stage kidney disease had been on maintenance hemodialysis for 18 years and was completely anuric. He presented with a two-week history of persistent low-grade fever (37 °C... more

Internal Medicine Flashcards

A hidden cause of sudden epigastric pain in a middle-aged man

4 April 2026
Author(s): Toshimasa Yamaguchi, Yuko Inoue

A 45-year-old man with a history of smoking and dyslipidemia presented with a 3-day history of sudden-onset epigastric pain that occurred while walking. The pain had largely subsided by the time of... more

Invited Review Article

From unmet needs to new possibilities: PPAR-targeted therapies in the journey of people living with Primary Biliary Cholangitis

15 April 2026
Author(s): Antonella Ruiu, Maria Pia Calabrese, Pietro Meschisi, Riccardo Plebani, Maria Buzias, Ana Lleo, Vincenzo Ronca

Primary biliary cholangitis (PBC) is a chronic autoimmune cholestatic liver disease characterized by progressive destruction of the small intrahepatic bile ducts. If is left untreated, the resulting... more

Erectile dysfunction and antihypertensive therapy: A critical reappraisal

9 April 2026
Author(s): Athanasios J Manolis, Manolis S Kallistratos, Maria Koutsaki, Nikolaos Papaioannou, Michael Doumas

Erectile dysfunction often coexists with arterial hypertension. They both share a common vascular pathophysiology, while antihypertensive treatment may also affect sexual function. Although some of... more

Letter to the Editor

Cumulative nocturnal hypoxemia, but not apnea-hypopnea index, is independently associated with vertebral fracture burden in obstructive sleep apnea

8 May 2026
Author(s): Francesco Bertoldo, Giulia Sartori, Matteo Lombini, Alberto Fantin, Ernesto Crisafulli

Obstructive sleep apnea (OSA) is a highly prevalent disorder characterized by recurrent upper airway collapse, intermittent hypoxemia, and sleep fragmentation [1]. Beyond its established... more

Timing of brain biopsy in cryptogenic neurological diseases: beyond diagnostic yield

4 May 2026
Author(s): Xin Wang, Sulong Zheng, Chao Sun

We read with great interest the study by Aboubakr et al [1] investigating the impact of brain biopsy timing on diagnostic yield and clinical outcomes in patients with neurological diseases of unknown... more

Rethinking renal protection in patients with heart failure and reduced ejection fraction

2 May 2026
Author(s): Wei Chen, Kexin Ye

We read with great interest the review titled “Renal protection in heart failure with reduced ejection fraction: not all that glitters is gold” by Elisa Russo and colleagues, published in your... more

Dialysis, but not severe renal dysfunction, is associated with excess bleeding in venous thromboembolism: Insights from a nationwide registry

2 May 2026
Author(s): Takahiro Kuno, Norimichi Koitabashi, Yugo Yamashita, Takeshi Morimoto, Hideki Ishii, on behalf of the COMMAND VTE Registry-2 Investigators

Venous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary embolism (PE), is a common and potentially fatal complication in patients with chronic kidney disease (CKD), including... more

Bedside-oriented new risk stratification in acute pulmonary embolism: Implications and clinical utility of the 2026 ACC/AHA guidelines compared with the 2019 ESC guidelines

27 April 2026
Author(s): Yugo Yamashita, Takeshi Morimoto, Ryuki Chatani, Koh Ono, Takeshi Kimura, on behalf of the COMMAND VTE Registry-2 Investigators

Recently, the American College of Cardiology (ACC) and American Heart Association (AHA) with scientific joint committees published the new clinical practice guidelines of acute pulmonary embolism (PE... more

Beyond the absolute value: A critical appraisal of the prognostic everest of lactate ratio in diabetic ketoacidosis

25 April 2026
Author(s): Yuan Yang, Wei Yang

We read with great interest the recent study by Sebastian-Valles F et al. published in the European Journal of Internal Medicine, titled " Pre- and in-hospital lactate ratio as a predictor of... more

Refining cerebrovascular risk in left atrial enlargement: integrating CKM framework and atrial cardiomyopathy phenotyping

24 April 2026
Author(s): Weikai Dong, Guangmin Yang, Qiang Wang

We read with great interest the article “Left atrial enlargement and 1-year cerebrovascular events in subjects without atrial fibrillation: A prospective cohort study” by Clerici et al. [1]. The... more

Uric Acid, Homocysteine, and comorbidities in sarcoidosis

21 April 2026
Author(s): Elias Giallafos, Ioannis Ilias, Evaggelos Oikonomou, Ourania Katsarou, Gerasimos Siasos

Sarcoidosis (SA) is a multisystem granulomatous disease with a highly variable clinical course. To-date, there are no validated circulating biomarkers capable of reliably predicting long-term outcome... more

Is there a clinical benefit of mechanical CPR in obesity? Author’s reply

20 April 2026
Author(s): Saurabh Sujanyal, Ivan Huespe, Aayushi Pareek, Devang Sanghavi, Nick Kelly

We thank Steffen et.al for their thoughtful and constructive comments regarding our study evaluating the use of mechanical versus manual CPR in obese patients with in-hospital cardiac arrest [1,2].... more

Beyond survival: nuances in the robustness of SGLT2 inhibitor evidence for HFpEF

20 April 2026
Author(s): Qi Sun, Longqing Yu

We read with great interest the article by Zuin et al., which provides a rigorous evaluation of the robustness of randomized controlled trial (RCT) evidence for sodium-glucose co-transporter 2... more

Heart failure and COPD – Disentangling undertreatment from the impact of severe comorbidities

15 April 2026
Author(s): Henning Johann Steffen, Michael Behnes, Ibrahim Akin, Tobias Schupp

We read with great interest the study by Vauterin et al. investigating the association between guideline-directed medical therapy (GDMT) and mortality in patients with heart failure (HF) hospitalized... more

Redefining “isolated” Whipple’s disease: bridging the gap between clinical phenotype and pathophysiological reality

14 April 2026
Author(s): Changyong Chen, Kaiwei Zhang, Haozhu Chen, Ji Fei

We read with great interest the article by Eiferman et al., entitled “Isolated joint involvement in Whipple’s disease: a cohort study”, recently published in the European Journal of Internal Medicine... more

eGFR imbalance and DOAC-VKA comparisons in kidney transplant recipients. Author’s reply

13 April 2026
Author(s): Michele Rossi, Gregory Y.H. Lip

We thank Jin et al [1] for the comment on methodological considerations regarding our study [2]. The observation of a higher mean eGFR in the DOAC group after propensity score matching (PSM) deserves... more

Universities and healthcare as privileged war targets. An urgent call for an international academic and institutional response to the attack on the Lebanese University and the health system

13 April 2026
Author(s): Mohamad Khalil, Agostino Di Ciaula, Piero Portincasa

Attacks on universities during armed conflicts represent a profound threat to individual lives but also to the institutions that sustain knowledge, scientific progress, and social stability [1]. In... more

Time and transitions in cardiogenic shock: making the Cath lab–CICU–cardiac step-down pathway reliable

13 April 2026
Author(s): Lukasz Szarpak, Katarzyna Karczewska, Jacek Smereka

While the ImCU models described by Canetta et al. and Turcato et al. arise from Internal Medicine, their broader relevance to cardiology lies not in patient case-mix, but in the principle that... more

The paradox of increasing cardiac amyloidosis hospitalizations and persistent diagnostic delays

13 April 2026
Author(s): Artur Dziewierz, Michał Susuł, Renata Rajtar-Salwa

The recent population-based study by Ojeda-Fernández et al [1], provides a valuable and timely perspective on the evolving epidemiology of cardiac amyloidosis (CA). Leveraging two decades of... more

Advancing precision, accountability, and implementation in antithrombotic stewardship

11 April 2026
Author(s): Anuradha Mokkapati, Rhushvi Thakkar, Anjna Rani, Dinesh Puri

We read with great interest the perspective by Ageno et al. addressing the urgent need for antithrombotic stewardship (ATS) within contemporary healthcare systems [1]. The synthesis of global data... more

Systemic inflammation and frailty in cirrhosis: Considerations regarding the role of the systemic immune-inflammation index

10 April 2026
Author(s): İbrahim Ethem Güven

I read with great interest the study by Sogbe et al. entitled “Inflammatory spectrum of frailty: Association between the systemic immune-inflammation index and frailty in liver transplant candidates... more

Baseline asymptomatic bacteriuria in high-risk hematological patients: Does low concordance adequately reflect its true invasive potential?

7 April 2026
Author(s): Zhikai Zhang

We read with great interest the article by Tolosa-Ridao et al. published in the European Journal of Internal Medicine [1]. This study examined the prevalence of baseline asymptomatic bacteriuria... more

Pathophysiological and prognostic implications of psychological distress in non-obstructive coronary syndromes: When the mind breaks the heart

4 April 2026
Author(s): Fuad A. Abdu, Abeer Essam Noman, Naif S. Al-barha, Aamer Aldbyani

Cardiovascular disease remains the leading cause of death worldwide [1], yet the field’s diagnostic and treatment strategies continue to target obstructive epicardial coronary artery disease... more

Methodological considerations for translating the STAMP score in intermediate-high-risk pulmonary embolism

30 March 2026
Author(s): Xiuhua Wang, Meiying Wang

We read with interest the study by Zuin and colleagues reporting the STAMP score for predicting 48-hour clinical deterioration in hemodynamically stable patients with intermediate-high-risk acute... more

From structure to function: A commentary on left atrial enlargement and cerebrovascular events and the potential value of left atrial strain

28 March 2026
Author(s): Man Luo, YiHuai Tian, Xun Ou

I read with great interest the article by Clerici and colleagues titled "Left atrial enlargement and 1-year cerebrovascular events in subjects without atrial fibrillation: A prospective cohort study... more

Right ventricular-pulmonary circulation uncoupling in older patients with acute HFpEF: is TAPSE/PASP ratio a dichotomous or continuous prognostic marker?

19 March 2026
Author(s): Giuseppe De Matteis, Maria Livia Burzo, Amato Serra, Giovanni Gambassi, Marcello Covino

We appreciated Pagnoni et al insightful comments [1] on our study as they raise important physiopathological and clinical questions that might further increase our understanding of right ventricular-... more

The Oral PCSK9 inhibitor enlicitide for hypercholesterolemia

14 March 2026
Author(s): Mohammed A. Elbahloul, Aliaa Gamal, Islam Y. Elgendy

Heterozygous familial hypercholesterolemia (HeFH) and other forms of severe hypercholesterolemia are characterized by lifelong elevation of low-density lipoprotein cholesterol (LDL-C), resulting in... more

Resting Heart Rate: a risk marker or factor for outcomes?

13 March 2026
Author(s): Elias Sanidas, Costas Thomopoulos

Resting heart rate (HR) remains one of the most routinely recorded yet paradoxically underappreciated cardiovascular parameters in clinical practice. Easily obtainable and highly reproducible, it... more

Training for prevention: exercise prescription as an Olympic discipline in the era of GLP-1 receptor agonists

10 March 2026
Author(s): Massimo Mapelli, Stefano Carugo, Elisabetta Salvioni, Piergiuseppe Agostoni

Dear Editor,

Causal inference and the risk of osmotic demyelination: A methodological critique of population-based hyponatremia research

9 March 2026
Author(s): Chunyan Chen

We read with great interest this population-based study derived from the Stockholm sodium cohort [1], which examined the association between early sodium correction rates in severe hyponatraemia and... more

Beyond acute severity: Age as a determinant of in-hospital mortality in acute respiratory failure requiring non-invasive respiratory support in an intermediate care unit

8 March 2026
Author(s): Giulia Sartori, Lorenzo Calabria, Ernesto Crisafulli

The increasing burden of acute illness, together with the progressive reduction in hospital bed capacity across Europe, has intensified the need for optimized management strategies for high-acuity... more

Optimizing cardiorenal protection in HFrEF: from pharmacological mechanisms to clinical implementation. Author's reply

6 March 2026
Author(s): Elisa Russo, Emilio Venturelli, Giovanna Leoncini, Francesca Viazzi, Roberto Pontremoli

We thank Dr. Yuan and coll. [1] for their interest in our review, Renal protection in heart failure with reduced ejection fraction: not all that glitters is gold [2], and for their comments on the... more

Refining the impact of epicardial adipose tissue assessment

3 March 2026
Author(s): Fabio Angeli, Giuseppe Calcaterra, Gianluca Iacobellis, Paolo Verdecchia

We read with great interest the correspondence by Momot et al. [1], which offers a thoughtful and constructive commentary on our recent narrative review exploring the role of epicardial fat... more

Personalizing PFO closure decisions: The emerging role of the CRISP-PFO score

2 March 2026
Author(s): Zi Diao

We read with great interest the recent article by Rigatelli et al. in the European Journal of Internal Medicine, describing the development and validation of the CRISP-PFO score for optimizing... more

Prehospital-to-hospital lactate ratio in severe hyperglycemic emergencies: how far can one cutoff travel?

2 March 2026
Author(s): Ziren Xu

Sebastian-Valles et al. reported that a prehospital-to-hospital lactate ratio <1.23 identifies a subgroup of patients with severe hyperglycemic emergencies at markedly higher risk of in-hospital... more

Transparency regarding publication charges in leading medical journals

2 March 2026
Author(s): Jason Joe Baker, Siv Fonnes, Jacob Rosenberg, Jesper Ryg

The code of conduct for research transparency guides authors to preregister protocols, adhere to reporting guidelines, and fully disclose funding sources and conflicts [1]. Although article... more

Residual respiratory events and daytime sleepiness despite management of obstructive sleep apnoea with and without additional central apnoeas. A three-month follow-up study. Authors’ reply

2 March 2026
Author(s): Michele Vitacca, Mara Paneroni, Nicolino Ambrosino

We thank Fan Yuan, and coll [1] and Linru Zhong and coll [2] for their interest in our study [3]. They add pertinent reflections and critical analysis of our study. We are aware of the unavoidable... more

Microvascular angina: it’s time to move beyond fixed paradigms

2 March 2026
Author(s): Stefano De Servi, Antonio Landi, Bernardo Cortese

Dear Editor,

Reconsidering “normal” in medicine

26 February 2026
Author(s): Marco Zuin, Gregory Piazza

“There are no norms. All people are exceptions to a rule that does not exist.”-Fernando Pessoa-

sTREM2 as an early MASH biomarker: a commentary on generalizability and mechanistic interpretation

24 February 2026
Author(s): Shiyu Peng, Shupeng Zhao, Hui Xiang, Yanling Wei

We read with great interest the study by Mahmoudian et al. investigating soluble TREM2 (sTREM2) as a non-invasive biomarker for early metabolic dysfunction-associated steatohepatitis (MASH) [1]. The... more

Long-term doctor–patient communication: a patient‑reported perspective from a large Italian survey

22 February 2026
Author(s): S. Harari, L. Ripamonti, P. Marveggio, P.M. Mannucci

Recent reports on long COVID and disability [1,2] have shown the value of large, patient‑reported web surveys in capturing dimensions of illness that are poorly described in traditional clinical... more

Rethinking scoring strategies for patient selection in PFO-related stroke

19 February 2026
Author(s): Yingxia Xie, Xueyuan Peng, Yuan Liu

We read with great interest the article regarding the CRISP-PFO score for optimizing patient selection for patent foramen ovale closure [1]. While refining risk stratification in patients with a Risk... more

Sotatercept for pulmonary arterial hypertension

18 February 2026
Author(s): Ahmed Samy Badran, Mohammed A. Elbahloul, Ahmed Sami Abuzaid, Islam Y. Elgendy

Pulmonary arterial hypertension (PAH) is a progressive, fatal disease driven by proliferative vascular remodeling. While current therapies targeting the endothelin, nitric oxide, and prostacyclin... more

Ostreopsis-related illness: An emerging and underrecognized clinical syndrome

17 February 2026
Author(s): Luca Bonanni, Marco Giannoccaro

Since the early 2000s, clusters of acute irritative and flu-like syndromes temporally associated with coastal exposure have been documented along Mediterranean shores, including Italy, France and... more

Reassessing SGLT2 Trials in HFpEF: When robustness and fragility coexist

13 February 2026
Author(s): Hu Liu, Qian Li, Hanning Zhang

Zuin and colleagues are to be commended for their rigorous reappraisal of sodium–glucose co-transporter 2 inhibitor (SGLT2i) trials in heart failure with preserved and mildly reduced ejection... more

Rethinking readmission prediction in multiple chronic conditions: Clinical utility over accuracy

12 February 2026
Author(s): Susana Garcia-Gutierrez, Amaia Pikatza, Anna Renom, Raul Quirós, Re-Pluris Working group

Hospital readmissions among patients with multiple chronic conditions (MCC) represent a persistent challenge in European healthcare systems, with rates approaching 20 % in Spain and similar figures... more

Access and Reimbursement Barriers to Guideline-Directed Cardiometabolic Therapy

12 February 2026
Author(s): Paschalis Karakasis, Dimitrios Patoulias, Antonios P Antoniadis, Nikolaos Fragakis, Ricardo Gómez-Huelgas

Cardiometabolic medicine is entering an era in which the most effective therapies are also among the least accessible. Glucagon-like peptide-1 receptor agonists (GLP-1RAs), sodium–glucose... more

Prevalence of aortic stenosis in patients with amyloidosis in northern Sweden

12 February 2026
Author(s): Kurt Boman, Mona Olofsson, Mathias Karlsson, Jonas Wixner

Amyloidosis and aortic stenosis seem to frequently occur together [1]. This has mainly been found in patients suffering from wild-type transthyretin amyloidosis (ATTRwt) [2]. It is still unclear... more

Refining checklist-based screening for transthyretin cardiac amyloidosis: Methodological and pathophysiological considerations

10 February 2026
Author(s): Li Nie, Shu Liu, Fengxia Xu

We read with great interest the study by Pérez-Nieva and colleagues regarding the implementation of a systematic checklist-based strategy for the screening of transthyretin cardiac amyloidosis (ATTR-... more

Cardiorenal anemia syndrome: Are we ready for paradigm shifts?

6 February 2026
Author(s): Michal Pruc, Lukasz Szarpak

To the Editor

Is there a clinical benefit of mechanical CPR in obesity?

2 February 2026
Author(s): Henning Johann Steffen, Ibrahim Akin, Tobias Schupp

We read with interest the article by Sujanyal et al. investigating the outcomes of LUCAS®-assisted versus manual cardiopulmonary resuscitation (CPR) in obese patients with in-hospital cardiac arrest... more

Unmeasured confounders in residual OSA: The roles of polypharmacy, loop gain, and weight trajectory

31 January 2026
Author(s): Linru Zhong, Xinhai Zhu

We read with interest the article by Vitacca et al. [1] In this retrospective cohort spanning ten years of cardiorespiratory monitoring (CRM), the authors assessed residual respiratory events (rAHI≥... more

Management of ANOCA and suspected microvascular angina: integration of plaque-directed and functional strategies

26 January 2026
Author(s): Lukasz Szarpak, Zbigniew Siudak, Andrea Denegri

We read with interest the Ideas and Opinions article by De Servi and colleagues, who question the current emphasis on invasive coronary function testing (CFT) in patients with angina with no... more

Reconsidering residual sleepiness and respiratory events in treated obstructive sleep apnea

23 January 2026
Author(s): Fan Yuan, Letian Qiao, Yuan Liu

We read with great interest the article by Vitacca and colleagues regarding the persistence of respiratory events and daytime sleepiness in patients treated for obstructive sleep apnea [1]. The study... more

Cerebral small vessel disease: a potential risk modifier for future guidelines on management of dyslipidaemias

22 January 2026
Author(s): Luca Bonanni

Cerebral small vessel disease (cSVD) is a highly prevalent and prognostically relevant condition in older adults, yet it is not specifically addressed in current dyslipidaemia management guidelines.... more

TAPSE/PASP ratio in older HFpEF patients: Prognostic insights and geriatric challenges

21 January 2026
Author(s): Gianluca Pagnoni, Aurora Vicenzi, Francesca Coppi

We read with interest the article by De Matteis et al. on the prognostic role of the TAPSE/PASP ratio in older patients with HFpEF hospitalized for acute heart failure [1]. The authors show that RV-... more

Epicardial adipose tissue assessment for earlier cardiovascular risk prediction: from association to clinical utility

18 January 2026
Author(s): Karol Momot, Michal Pruc, Bartosz Maj, Lukasz Szarpak

Calcaterra and colleagues provide a timely narrative review on epicardial adipose tissue (EAT) as an imaging marker of cardiometabolic risk and a potentially modifiable therapeutic target [1]. Yet... more

Use of continuous morphine infusions in end-of-life care in an internal medicine ward

16 January 2026
Author(s): Matilde Ribeiro-Coimbra, Maria Carolina-Carvalho, Frederico Luís-Batista, Paulo Reis-Pina

The use of continuous opioid infusions at the end of life remains a clinically and ethically sensitive area in acute hospital practice[1,2]. International recommendations emphasize that opioids are... more

Optimizing cardiorenal protection in HFrEF: From pharmacological mechanisms to clinical implementation

11 January 2026
Author(s): Miao Yuan

We read with great interest the review article by Russo et al. titled [1]. The authors provided a comprehensive and timely overview of the "four pillars" of heart failure therapy—RAAS inhibitors,... more

Comparison of primary prevention strategy guided by SCORE2 versus coronary artery calcium scoring in a non-diabetic population

7 January 2026
Author(s): Anthony MATTA, Dorota FERRIERES, Pauline COUGOUL, Vanessa NADER, Didier Carrié, Vanina BONGARD, Jean FERRIERES

Cardiovascular disease (CVD) remains the leading cause of death and disability worldwide [1]. The role of preventive medicine in reducing the burden of CVD tends to grow because prevention is better... more

Clinical incidents attended by the internal medicine on-call team at a tertiary care hospital

5 January 2026
Author(s): Victoria Lobo-Antuña, Laura Abenza-Barberá, Francesc Puchades-Gimeno, José Chordá-Ribelles, Sara Carrascosa-García

On-call duty is a cornerstone of hospital-based Internal Medicine, yet it remains one of the least quantified and most debated components of medical practice. Originally conceived to address... more

Survival outcomes with LUCAS-AssiSTED VS MANUal CPR in in-hospital cardiac arrest obese patients

3 January 2026
Author(s): Saurabh Sujanyal, Ivan Huespe, Aayushi Pareek, Devang Sanghavi, Nick Kelly

Obesity has emerged as a global health challenge, contributing not only to chronic disease but also to poorer outcomes in acute, high-acuity situations such as cardiac arrest. In the in-hospital... more

Methodological and generalizability considerations in the study of bleeding risk with rivaroxaban vs apixaban in older VTE patients

1 January 2026
Author(s): Fuli Liu, Yuanming Ba

We read with great interest the nationwide register-based cohort study by Roupe et al., recently published in the European Journal of Internal Medicine [1]. The authors should be commended for... more

Antiplatelet therapy in patients with stable coronary artery disease who require long-term oral anticoagulation

29 December 2025
Author(s): Laurent Fauchier, Mickael Guglieri, Arnaud Bisson, Thibault Lenormand, Gregory Y.H. Lip

Coronary artery disease (CAD) and atrial fibrillation (AF) and frequently coexist, with overlapping cardiovascular risk factors [1]. Oral anticoagulants (OACs) are indicated for AF-related stroke... more

Refining cardio-kidney-metabolic phenotyping to strengthen interpretation and clinical translation in atrial fibrillation

28 December 2025
Author(s): Qianqian Yang, Jiaqi Xu, Yu Qiu, Ke Chen, Xiangdong Yang

We read with great interest the article by Mei and colleagues, who investigated cardiovascular-kidney-metabolic (CKM) domains in a large European cohort of patients with atrial fibrillation (AF) and... more

SGLT2 Inhibitors in musculoskeletal and connective tissue diseases: Is there a role?

28 December 2025
Author(s): Margarida Lucas Rocha, Vítor Silvestre-Teixeira

Dear Editor,

Quality-of-life outcomes after sleeve gastrectomy versus Roux-en-Y gastric bypass: looking beyond mean differences

23 December 2025
Author(s): Adila Abdulla, Chao Li

We read with great interest the article by ’t Hart et al. reporting long-term quality of life (QoL) outcomes after sleeve gastrectomy (SG) and Roux-en-Y gastric bypass (RYGB) in the SleeveBypass... more

Heart failure with preserved ejection fraction in the elderly: Clinical, imaging, and biomarker profiles according to global longitudinal strain by cardiac magnetic resonance

15 December 2025
Author(s): Pau Llàcer, Marina García Melero, María Ángeles Fernández, Pedro Torres, Luis Manzano

Dear editor,

Beyond ejection fraction: Small left ventricular volumes define a high-risk phenotype in acute heart failure with preserved ejection fraction

10 December 2025
Author(s): Gema Miñana, Ernesto Valero, Hector Merenciano, Vicent Bodí, Julio Núñez

In patients with heart failure and reduced ejection fraction (HFrEF), larger indexed left ventricular volumes (iLVEDV) have been traditionally considered a surrogate of lower left ventricular... more

Communicating robustness and sex-specific benefit of SGLT2 inhibitors in HFpEF and HFmrEF

9 December 2025
Author(s): Qiang Li, Haixu Hao, Xiaoxuan Yue, Meng An, Yun Yue

Dear Editor,

Integrating sTREM2 into non-invasive pathways for early MASH in MASLD

8 December 2025
Author(s): Wenqi Lv, Xiaoyan Yan

We read with great interest the article by Mahmoudian et al., who evaluated soluble triggering receptor expressed on myeloid cells 2 (sTREM2) as a non-invasive biomarker for early metabolic... more

Beyond systemic biomarkers: Future directions in understanding the inflammatory nexus of obstructive sleep apnea and atrial fibrillation

8 December 2025
Author(s): Qianhui Niu

We read with great interest the article by Hunt et al. entitled “Systemic markers of inflammation and immune activation in patients with obstructive sleep apnea and paroxysmal atrial fibrillation,”... more

Original Article

Discharge medical treatment implementation and predictors of a successful decongestion in patients with acute heart failure: first data from the BRING-UP 3 Heart Failure Study

8 May 2026
Author(s): BRING-UP 3 Heart Failure Investigators

Current discharge management of acute heart failure patients and clinical predictors of successful decongestion in a large Italian network of cardiology sites.AF, atrial fibrillation; BMI, body mass... more

Early vasopressin administration in septic shock: A systematic review, meta-analysis, and multicenter retrospective observational study

7 May 2026
Author(s): Chiwon Ahn, Gun Tak Lee, Jae Hwan Kim, Sejoong Ahn, Sung Yeon Hwang, Sang-Min Kim, Won Young Kim, Sung-Joon Park, Sung-Hyuk Choi, Woon Yong Kwon, Taeyoung Kong, Sung Phil Chung, Byuk Sung Ko, Kyung Hun Yoo, Tae Ho Lim, Tae Gun Shin, Kyuseok Kim, Korean Shock Society

To determine the optimal timing for initiating vasopressin in septic shock.

Hypertension and blood pressure profiles in patients with acute intermittent porphyria: a prospective case-control study

7 May 2026
Author(s): Krzysztof Jaworski, Robert Wasilewski, Jerzy Windyga, Ilona Kowalik, Hanna Szwed, Agnieszka Lipniacka, Magdalena Niedolistek, Joanna Was, Andrzej Januszewicz, Reinhold Kreutz, Franz Messerli, Rafal Dabrowski

Acute intermittent porphyria (AIP), a rare disorder of heme biosynthesis, may manifest with neurovisceral crises affecting autonomic regulation. This study aimed to assess blood pressure (BP) pattern... more

Relationship between T90 and systemic hypertension in patients with obstructive sleep apnea: Data from the European sleep apnea database

4 May 2026
Author(s): MS Tasbakan, S Svedmyr, J Bergqvist, H Hein, S Mihaicuta, Z Dogas, G Trakada, F Fanfulla, P Joppa, D Testelmans, O Ludka, M Drummond, S Matthes, H Gouveris, R Staats, OK Basoglu, ESADA Study Group

Obstructive sleep apnoea (OSA) is a sleep disorder characterized by a partial or complete cessation of upper airway during sleep. It is estimated that approximately one billion individuals between... more

Specialist or generalist management of emergency medical admissions - immediate and long-term outcomes

2 May 2026
Author(s): Richard Conway, Declan Byrne, Deirdre O’Riordan, Bernard Silke

To study whether the admission of unselected emergency medical patients, under either a Consultant with General Medicine (GIM) or Specialist accreditation, influenced either short or longer-term all-... more

Hospital-to-community care pathways for patients with heart failure, an inter-society consensus document

1 May 2026
Author(s): Mario Mallardo, Pasquale Perrone Filardi, Claudio Micheletto, Nicola Montano, Andrea Spampinato, Maurizio Volterrani, Giovanni Battista Zito, Sergio Agosti, Enrico Avogadri, Christian Basile, Michele Gabriele, Alberto M. Marra, Anna Vittoria Mattioli, Alex Micanti, Savina Nodari, Ugo Oliviero, Stefania Paolillo, Gennaro Ratti, Antonio Ruvolo, Andrea Salzano, Regina Sorrentino, Antonio Cittadini

Heart failure (HF), defined as the inability of the heart to meet the metabolic requirements of peripheral tissues, or to do so only at the expense of elevated ventricular filling pressures,... more

Effects of urine uromodulin levels on the association between sodium intake and ambulatory blood pressure in individuals with chronic kidney disease

25 April 2026
Author(s): Artemios G. Karagiannidis, Amalia Baroutidou, Marieta Theodorakopoulou, Eleni Karkamani, Sofia Manti, Zoi Afkou, Eleni Vagdatli, Danai Faitatzidou, Panagiotis Giamalis, Christodoulos Papadopoulos, Pantelis Sarafidis

In CKD, hypertension is often accompanied by sodium sensitivity. Uromodulin promotes sodium sensitivity by activating tubular sodium transporters (NKCC2, NCC). In the general population, individuals... more

Efficacy of Aldosterone synthase inhibitors in uncontrolled and resistant hypertension: A systematic review and updated meta-analysis with grade assessment

23 April 2026
Author(s): Mrunalini Dandamudi, Alisha Ahmed, Muhammad Sharjeel Abbas, Muhammad Huzaifa Khattak, Navya Mandalapu, Terezia Toni Khairallah, Larissa Araújo de Lucena, Jonida Pjetrushaj

The current therapy for resistant hypertension is often limited by hyperkalemia, renal decline, and a failure to prevent compensatory increases in circulating aldosterone. The aldosterone synthase... more

Prognostic impact of percutaneous coronary intervention in acute coronary syndrome vs. elective settings in heart transplant recipients

23 April 2026
Author(s): Luisa Elbinger, Tobias Schupp, Michael Behnes, Ibrahim Akin, Angelika Costard-Jäckle, Kambis Mashayekhi, Tanja K. Rudolph, Jan Gummert, Rene Schramm, Volker Rudolph, Mohamed Ayoub

Cardiac allograft vasculopathy (CAV) affects >50% of patients following heart transplantation (HTX) within ten years and is one of the main reasons for late graft failure. The study aimed to... more

Fatty acid binding protein 4, resistin, diastolic dysfunction, and cardiovascular risk in patients with rheumatoid arthritis

22 April 2026
Author(s): Mariusz Ciołkiewicz, Anna Kuryliszyn-Moskal, Ewa Jabłońska, Wioletta Ratajczak-Wrona, Agnieszka Dakowicz, Piotr A. Klimiuk

Rheumatoid arthritis is a chronic autoimmune disease associated with CV system involvement [1]. Cardiovascular mortality and incidence of major adverse cardiovascular events (MACE) are increased by... more

Cocaine-induced ANCA-associated vasculitis: Cohort analysis from a referral center and literature review

21 April 2026
Author(s): Nuria Garvín Grande, María Pilar Ortiz-Lavín, Vanesa Calvo-Río, Fabricio Benavides-Villanueva, Carmelo Morales-Angulo, Juan Irure-Ventura, Diana Prieto-Peña, Victor M Martínez-Taboada, Ricardo Blanco

Cocaine adulterated with levamisole has been implicated as a trigger of Cocaine-Levamisole-Associated Autoimmune Syndrome (CLAAS), frequently mimicking granulomatosis with polyangiitis (GPA).

Venous thromboembolism risk assessment in hospital-at-home setting: A prospective cohort study (the TROMBODOM study)

18 April 2026
Author(s): Joao Modesto Dos Santos, Iñigo Les Bujanda, Paula Etayo-Urtasun, Julio Sánchez Álvarez, Mikel Izquierdo, Mikel L. Sáez De Asteasu, María Ruiz Castellano, Begoña Llorente Diez, Silvia Salinas Urra, Marta Pulido Fontes, Ramón Lecumberri

Venous thromboembolism (VTE) is a significant cause of preventable mortality in hospitalized patients. While risk assessment models such as Padua and IMPROVE-VTE scores have been validated in... more

Early brain biopsy in neurological diseases of unknown etiology improves functional outcome

13 April 2026
Author(s): Oumaima Aboubakr, Karima Mokhtari, Lucia Nichelli, Franck Bielle, Sophie Demeret, Anne-Laure Dubessy, Sonia Alamowitch, Marc Pineton De Chambrun, Alexandre Le Joncour, Valérie Pourcher, Ahmed Idbaih, Bertrand Mathon

Brain biopsy is established for diagnosing non-resectable neoplastic lesions, with yields approaching 95%, and for documenting brain infections [1,2]. However, the indications and timing of brain... more

Cause-specific mortality in patients with chronic pancreatitis: a nationwide population-based cohort study

10 April 2026
Author(s): Line Davidsen, Niels Henrik Bruun, Mathias E. Cook, Jens Brøndum Frøkjær, Asbjørn M. Drewes, Dhiraj Yadav, Søren S. Olesen

Cause-specific mortality in chronic pancreatitis changes over time. Early deaths are driven by pancreatitis-related deaths and liver disease, whereas extra-pancreatic cancers, respiratory, and... more

Shaping rheumatoid arthritis treatment: Clinical and demographic drivers of tsDMARDs versus bDMARDs prescription post-EMA pronouncement on JAK inhibitors. Insights from the AMBI-RA study

25 March 2026
Author(s): Riccardo Bertola, Beatrice Maranini, Carlo Garaffoni, Maria Pozzuto, Anna Laura Riva Cambrino, Alessandro Spinelli, Marcello Govoni, Alessandra Bortoluzzi, Ettore Silvagni

Rheumatoid arthritis (RA) is a chronic autoimmune disease leading to progressive joint damage and functional disability [1,2]. The treatment landscape for RA has evolved substantially over the last... more

Prevalence of asymptomatic bacteriuria in high-risk hematological patients and its association with bacteremia: A prospective observational study on the need for antibiotic treatment

23 March 2026
Author(s): C. Tolosa-Ridao, T. Villalobos, L. Gómez, L. Boix-Palop, M. Xercavins, A. Sangil, M. Canet, A. Mesa, M. López, A. Muntañola, F. Vall-llovera, JM Martí, M. Julià, R. Santiago, G. Bustamante, E. Viladot, B. Dietl, A. Jaén, M. Rodríguez-Carballeira, P. Pérez, E. Calbo

Antibiotic treatment for asymptomatic bacteriuria (AB) is not recommended in the general population, and its significance in oncohematological patients remains unclear.

Distinct miRNA expression profiles in subcutaneous and visceral adipose tissue of gastrointestinal cancer patients and their modulation based on adiposity level assessed by CT-scan

20 March 2026
Author(s): Federica Tambaro, Giovanni Imbimbo, Valentina Pace, Simona Orlando, Elena Belloni, Giuseppe Nigri, Veronica Rizzo, Orietta Picconi, Maria Ida Amabile, Maurizio Muscaritoli, Alessio Molfino

Metabolic and nutritional derangements during cancer are often characterized by significant loss of body weight, primarily due to the wasting of skeletal muscle and adipose tissue [1,2].

Long-term mortality in patients with first-time pulmonary embolism according to the presence of comorbidities at baseline: a nationwide register study

19 March 2026
Author(s): Mazdak Tavoly, Kristina Svennerholm, Jacob Philipson, Aldina Pivodic, Sam Schulman, Annika Rosengren, Maria Roupe, Katarina Glise Sandblad

Venous thromboembolism (VTE), encompassing pulmonary embolism (PE) and deep vein thrombosis (DVT), represents a significant global health burden due to high morbidity and mortality rates associated... more

Rituximab limits glucocorticoid use in IgG4-related disease: Real-world evidence from a large European cohort

19 March 2026
Author(s): Jens Vikse, Marco Lanzillotta, Elisabetta Goni, Bjørg-Tilde Svanes Fevang, Øyvind Midtvedt, Jasmin Mahajne, Veronica Batani, Giovanni Benanti, Georg Beyer, Lorenzo Dagna, Øyvind Molberg, Katrine Brække Norheim, Cathrine Brunborg, Ulf Schönermarck, Ivonne Regel, Julia Mayerle, Emanuel Della-Torre, Anna-Maria Hoffmann-Vold

While the rituximab-treated patients in this study had more severe IgG4-RD than the glucocorticoid-treated comparators, treatment with rituximab was associated with similar effectiveness endpoints,... more

Lifestyle characteristics and plasma biomarkers for risk of MASLD differ by sex in the general population

16 March 2026
Author(s): Lærke Kristine Kyhl, Børge Grønne Nordestgaard, Anne Tybjærg-Hansen, Michael Huy Cuong Pham, Jørgen Tobias Kühl, Klaus Fuglsang Kofoed, Sune Fallgaard Nielsen

The rise in global prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) has highlighted the importance of developing sex-specific risk profiles for MASLD based on readily... more

Hydroxychloroquine for recurrent pericarditis: A multicentre observational study

16 March 2026
Author(s): Lucia Trotta, Francesco Agozzino, Silvia Berra, Ruggiero Mascolo, Francesco Rubuano, Olga Blagova, George Lazaros, Elisa Ceriani, Massimo Pancrazi, Angela Mauro, Emilia Lazarou, Nicola Marotta, Francesca Casarin, Ludovico L. Sicignano, Massimo Imazio, Antonio Brucato

To assess the effect of hydroxychloroquine (HCQ) in recurrent pericarditis (RP).

Guideline-directed medical therapy and mortality in heart failure patients hospitalized for COPD exacerbation

14 March 2026
Author(s): Delphine Vauterin, Frauke Van Vaerenbergh, Maxim Grymonprez, Nathaniel M. Hawkins, Leonardo M. Fabbri, Lies Lahousse

Heart failure (HF) is highly prevalent (≥ 15-20%) among patients with chronic obstructive pulmonary disease (COPD) and associated with increased mortality [1,2]. In addition, approximately 20% of HF... more

Optical coherence tomography angiography: a window on systemic sclerosis microangiopathy

14 March 2026
Author(s): Martina Orlandi, Tommaso Verdina, Filippo Santoro, Mohammed El Alouani, Matteo Gibertini, Mariagrazia Nuara, Alessandra Carobbio, Giorgia Roveta, Amelia Spinella, Marco De Pinto, Giuseppe Querques, Dilia Giuggioli

Systemic sclerosis (SSc) is a rare multisystem disease characterized by early microvascular damage that leads to fibrosis of skin and internal organs [1]. SSc-related ocular manifestations have been... more

Exercise testing in chronic thromboembolic pulmonary hypertension and chronic thromboembolic pulmonary disease without pulmonary hypertension: a comprehensive systematic review and meta-analysis

13 March 2026
Author(s): Filippo Biondi, Valerio Di Fiore, Roberta Pancani, Laura Carrozzi, Raffaele De Caterina, Rosalinda Madonna

The role of exercise testing in the follow up of patients with persistent dyspnea after pulmonary embolism (PE) is currently limited, with cardiopulmonary exercise test (CPET) mainly recommended in... more

All-cause mortality and early cardiovascular complications in relation to lesion location and stroke subtype in haemorrhagic and ischaemic stroke: the Perugia stroke registry

13 March 2026
Author(s): Andrea Galeazzo Rigutini, Maurizio Paciaroni, Maria Giulia Mosconi, Virginia Cancelloni, Chiara Urbini, Michele Marvardi, Carmen Rapuano, Allegra Gaboni, Alessandro Bufi, Tommaso Bucci, Cecilia Becattini, Gregory Y.H. Lip, Valeria Caso

Stroke is a major global cause of morbidity and mortality and is frequently complicated by early cardiovascular events, collectively referred to as stroke-heart syndrome (SHS)[1,2]. The SHS... more

Risk of infection shortly before and after a diagnosis of liver cirrhosis: a nationwide, population-based study in Sweden

10 March 2026
Author(s): Pia Anna Steimer, Axel Wester, Qing Shen, Hannes Hagström, Ying Shang

Liver cirrhosis is a serious medical condition and an increasing cause of mortality and morbidity worldwide [1–3] Cirrhosis poses a major burden on health systems, with patients having high risk of... more

From hospital to home: Practical guidance when caring for patients with COPD and heart disease

8 March 2026
Author(s): Claus F Vogelmeier, Michael Böhm, John R Hurst, Kathrin Kahnert, Tobias J Lange, Christian Taube, Frederik Trinkmann, Henrik Watz, Klaus F Rabe, Daiana Stolz, Michael Gediga, Leonardo M Fabbri

Patients with chronic obstructive pulmonary disease (COPD) frequently suffer from other chronic conditions, with cardiovascular disease being especially common. The presence of cardiovascular disease... more

Morning urinary calcium/creatinine ratio as a sex-specific screening tool for detecting hypercalciuria in hypoparathyroidism

27 February 2026
Author(s): Christina M. Berr, Carmina T. Fuss, Karen Gronemeyer, Birgit Löhr, Christian H. Pfob, Thomas Pusl, Stefanie Hahner

Hypercalciuria is a relevant complication in patients with treated hypoparathyroidism. While hypercalciuria is usually estimated by 24-hour urinary calcium excretion (24hUCa), the calcium/creatinine... more

When social issues become medical emergencies: Prevalence and patient characteristics of social emergency admissions in internal medicine

25 February 2026
Author(s): MA Baumgartner, F Rutishauser, C Müller, M Boch, S Neuner-Jehle, BL Hug, PE Beeler

Hospitalisations constitute the largest share of healthcare expenditures, and recent evidence suggests that a growing number of admissions are driven primarily by non-acute or non-medical factors... more

Trends in cardiac amyloidosis hospital admissions and associated mortality risk over 20 years: a population-based study using healthcare administrative databases

25 February 2026
Author(s): Luisa Ojeda-Fernández, Claudio Cimminiello, Patrick Prada, Mauro Molteni, Mauro Tettamanti, Ida Fortino, Marta Baviera

Cardiac amyloidosis (CA) remains substantially underdiagnosed despite greater awareness. This study evaluated hospital admissions for CA as a proxy of its incidence in Lombardy over the last two... more

Peripheral ulcerative keratitis (PUK) in autoimmune diseases: a severe ocular manifestation not always associated with systemic disease activity

23 February 2026
Author(s): Laura Pelegrín, Olga Araújo, Gerard Espinosa, Ignasi Rodríguez-Pintó, Raimon Sanmartí, Andrés Ponce, Verónica Gómez-Caverzaschi, Fátima Raad, Jesús Cívico, Josep Torras-Sanvicens, Ramón Quintana, Alex Fonollosa, Luca Cantarini, Claudia Fabiani, Maite Sainz-de-la-Maza, José Hernández-Rodríguez

Peripheral ulcerative keratitis (PUK) is a rare and severe ocular manifestation frequently associated with systemic autoimmune diseases. This retrospective two-center observational study including... more

Assessing the proportion of patients with type 2 diabetes in tertiary care eligible for combination therapy with GLP-1 receptor agonist and SGLT2 inhibitors

23 February 2026
Author(s): Anders B. Jensen, Frida Renström, Michael Brändle

That almost half of the patients with type 2 diabetes in tertiary care were eligible for combination therapy with GLP-1 RA and SGLT2i highlight the potential negative impact of restricting access to... more

Left atrial enlargement and 1-year cerebrovascular events in subjects without atrial fibrillation: A prospective cohort study

20 February 2026
Author(s): Bianca Clerici, Giovanni Casazza, Antonio Russo, Laura Massironi, Antonella Moreo, Viola Dadone, Simone Birocchi, Francesca Bursi, Andrea Bonelli, Paolo Mattiello, Francesca Casanova, Chiara Pisetta, Mariangela Scavone, Marco Guazzi, Cristina Giannatasio, Simona Pierini, Giancarlo Agnelli, Gian Marco Podda

Left atrial enlargement (LAE) is a cardiac structural abnormality linked to adverse cardiovascular events, including stroke. However, its independent prognostic role in patients without atrial... more

Efficacy and harms of polypills for cardiovascular disease prevention: A systematic review and meta-analysis of randomized controlled trials

19 February 2026
Author(s): Brian M. Portela, Ryan M. Shan, Lahar Miriyapalli, Vinay Pasupuleti, Carlos Diaz-Arocutipa, Adrian V. Hernandez

To systematically evaluate polypill effects on cardiovascular (CV) risk factors, CV outcomes, and adverse events in CV disease (CVD) prevention populations.

Major adverse cardiovascular and bleeding outcomes in paroxysmal vs. non-paroxysmal atrial fibrillation: an individual patient-level data analysis of a large cohort of patients from the COMBINE-AF

18 February 2026
Author(s): George Ntaios, Andreas Goette, Michael G. Palazzolo, Christian Ruff, Mark S. Link, Kenneth W. Mahaffey, Anthony P. Carnicelli, John Eikelboom, Christopher B. Granger, Manesh Patel, Lars Wallentin, Robert P. Giugliano

Background: We performed an individual patient data analysis of COMBINE AF to assess differences in 14 clinically relevant outcomes between patients with paroxysmal (PAF) vs. non-PAF.Methods: Cox-... more

MBL2 deficiency and IgA Nephropathy in transplant patients: Is complement inhibition always beneficial?

18 February 2026
Author(s): Emma Diletta Stea, Francesco Pesce, Ighli di Bari, Rossana Franzin, Michele Rossini, Simona Simone, Fausta Piancone, Fabio Sallustio, Arianna De Palma, Maria Antonietta Grignano, Paola Pontrelli, Marilena Gregorini, Tefik Islami, Teresa Rampino, Giuseppe Castellano, Loreto Gesualdo

Immunoglobulin A nephropathy (IgAN) represents the most prevalent form of primary glomerulonephritis globally and constitutes a major contributor to the burden of end-stage renal disease (ESRD) [1].... more

The changing prognosis of infective endocarditis. A 15-year analysis

14 February 2026
Author(s): Manuel Martínez-Sellés, Patricia Muñoz, Maricela Valerio, María Carmen Fariñas, Aristides de Alarcón, Raquel Rodríguez-García, Miguel Ángel Goenaga-Sánchez, Ane Josune Goikoetxea, Guillermo Ojeda-Burgos, Elisa García-Vázquez, María Dolores Sousa-Regueiro, José M. Miró, Antonio Ramos-Martínez, Spanish Collaboration on Endocarditis - Grupo de Apoyo al Manejo de la Endocarditis Infecciosa en España (GAMES)

Infective endocarditis (IE) mortality remains high. Population aging makes the aim of improving IE prognosis particularly difficult, as age is associated with comorbidity and mortality. Our objective... more

Genetic, and clinical features in Italian and lebanese subjects with familial mediterranean fever (FMF)

7 February 2026
Author(s): Nour Jaber, Mohamad Khalil, Hala Abdallah, Laura Mahdi, Vita Giordano, Ahmad Daher, Fatima Shamesseddin, Ghassan Ghssein, Nicoletta Resta, Agostino Di Ciaula, Alessandro Stella, Piero Portincasa

Familial Mediterranean Fever (FMF) is a hereditary autoinflammatory disease with variable manifestations across Mediterranean regions. This study compares FMF cohorts from Italy (Apulia) and Lebanon... more

Direct oral anticoagulants versus Vitamin K antagonist in kidney transplant recipients with atrial fibrillation: A study from a global federated research network

7 February 2026
Author(s): Michele Rossi, Enrico Tartaglia, Amir Askarinejad, Andrea Galeazzo Rigutini, Muath Alobaida, Anirudh Rao, Louise Oni, Claudio Ferri, Tommaso Bucci, Gregory Y.H. Lip

The risk-benefit profile of direct oral anticoagulants (DOACs) in kidney transplant recipients (KTRs) with atrial fibrillation (AF) remains under-investigated.

Identifying distinct clinical phenotypes and outcomes in adult-onset IgA vasculitis using unsupervised clustering analysis

4 February 2026
Author(s): Valentin Maisons, Antoine Hankard, Alojzija Hočevar, Evangeline Pillebout, Jean-Michel Halimi, Bénédicte Sautenet, Christelle Barbet, Noémie Jourde-Chiche, Alexandre Karras, Jean-François Augusto, Xavier Puéchal, Stanislas Faguer, Christian Lavigne, Kim Baud, Alexis Archambeaud, Hubert de Boysson, Achille Aouba, François Maillot, Benjamin Terrier, Yann Nguyen, Alexandra Audemard-Verger

IgA vasculitis (IgAV) is a systemic vasculitis of the small vessels characterized by immune complexes including immunoglobulin A1 (IgA1) [1]. The clinical picture is a vascular purpura with or... more

Incidence of major adverse cardiovascular events decreases with greater adherence to both Mediterranean and low-fat dietary patterns in secondary prevention patients: a randomized controlled trial

27 January 2026
Author(s): Javier Delgado-Lista, Juan F Alcala-Diaz, Jose D Torres-Peña, Gracia M Quintana-Navarro, Antonio P Arenas Larriva, Francisco Fuentes, Antonio Garcia-Rios, Elena M Yubero-Serrano, Oriol A Rangel-Zuñiga, Antonio Camargo, Fernando Rodriguez-Cantalejo, Niki Katsiki, Pablo Perez-Martinez, Jose Lopez-Miranda, CORDIOPREV Investigators

Diet plays a crucial role in lifestyle interventions for secondary cardiovascular prevention [1–5]. Recent guidelines for reducing cardiovascular risk in secondary prevention populations recommend,... more

Mechanistic insights into heart failure progression and therapeutic target discovery through plasma microRNA profiling: Findings from HOMAGE

26 January 2026
Author(s): David de Gonzalo-Calvo, María C. García-Hidalgo, Shambhabi Chatterjee, Sabrina Thum, João Pedro Ferreira, Patrick Rossignol, Nicolas Girerd, Job AJ Verdonschot, Stephane Heymans, Jan A Staessen, John GF Cleland, Faiez Zannad, Thomas Thum, Christian Bär

Identifying early pathobiological mechanisms associated with the onset and progression of heart failure (HF) could guide development of preventive strategies.

Left atrial appendage closure in patients with hereditary hemorrhagic telangiectasia and atrial fibrillation: a prospective study and systematic review

6 January 2026
Author(s): R Torres-Iglesias, L Teruel, MA Sánchez-Corral, P Cerdà, B Villanueva, E Gamundí, P Peláez, S Moreno-Lopes, A Iriarte, E Alba, A Portillo, J Gómez-Lara, J Ribas, A Riera-Mestre

Hereditary hemorrhagic telangiectasia (HHT) is a rare autosomal dominant vascular disease with a high risk of iron deficiency anemia secondary to epistaxis and gastrointestinal bleeding. Atrial... more

Review Article

Assessment and management of cardiovascular–kidney–liver metabolic-syndrome in the primary care setting: A multidisciplinary consensus statement

27 April 2026
Author(s): Reinhold Kreutz, Ali Canbay, Martin Haluzik, Andrzej Januszewicz, Juan M. Mendive, Pantelis Sarafidis, Jörn M. Schattenberg

The recently introduced cardiovascular–kidney–metabolic (CKM) syndrome captures the close interplay between metabolic risk factors, chronic kidney disease, and cardiovascular disease, but... more

Organization and delivery of home-based care for chronic obstructive pulmonary disease patients receiving long-term home non-invasive ventilation: a systematic review

13 April 2026
Author(s): Claudia Crimi, Simon Oczkowski, Annalisa Carlucci, Jean-Louis Pépin, Juliane Hafermann, Anya Lissina, Rhodri Saunders, Sarah Alami, Scott Gibson

The delivery of LTHNIV remains heterogeneous, even within countries. This variability in care organization and reporting mandates establishing harmonized, patient-centred pathways that integrate... more

Trigger-induced atrial fibrillation for the hospitalist: a review

13 April 2026
Author(s): Barat S. Venkataramany, Aparna Kambhampati, Alexander Arora, Sarah Horn

Atrial fibrillation (AF) is a common arrhythmia that a hospitalist may encounter. It is known to occur transiently or in response to specific triggers (trigger-induced AF), which presents a challenge... more

“Unpatients” in haemostasis and thrombosis. A yardstick of current paths in healthy carriers of a genetic susceptibility

8 April 2026
Author(s): Giovanni Di Minno

Thrombophilia is defined as either an inherited or acquired abnormality of haemostasis inclining affected subjects to thrombosis, mainly because of interaction of multiple inherited and/or acquired... more

Alcohol use: less is better. An umbrella systematic review of clinical interventions, policies, and dose–response health risks in adults

24 March 2026
Author(s): Tommaso Dionisi, Vittorio De Vita, Giovanna Di Sario, Antonio Gasbarrini, Giovanni Addolorato, the“Alcohol Research” Group

Alcohol is a major modifiable cause of morbidity, premature mortality and health inequalities, yet evidence informing “low-risk” thresholds and prevention strategies is fragmented.

Chronic therapeutic non-adherence: Toward a new nosological entity

16 March 2026
Author(s): Federica Moscucci, Francesco Baratta, Stefano Necozione, Giovambattista Desideri

In 2021, non-communicable diseases caused approximately 43.8 million deaths and 1.73 billion DALYs globally, posing a major challenge for healthcare systems [1]. Despite significant advances in... more

Discontinuation of incretin-based therapies in obesity: the complexity of a breakup

13 March 2026
Author(s): Angelo Avogaro, Gian Paolo Fadini

Incretin-based therapies, including mono-, dual-, and emerging triple-agonists, have transformed the pharmacological management of obesity by inducing substantial and sustained weight loss together... more

How to monitor disease progression in ATTR amyloid cardiomyopathy: Implications for clinical practice and trial design

20 February 2026
Author(s): Aldostefano Porcari, Sarah AM Cuddy, Marco Metra, Michele Emdin, Marianna Fontana, Julian D Gillmore

Transthyretin amyloid cardiomyopathy (ATTR-CM) has been traditionally considered a rare and inexorably fatal condition. However, the development of therapies able to slow or halt ATTR-CM progression... more

Pitfalls of autoimmune serological markers and practical diagnostic workflows in connective tissue diseases and rheumatoid arthritis

18 February 2026
Author(s): Chiara Bellocchi, Lorenzo Beretta, Nicola Montano

Laboratory markers represent a highly valuable tool to support the diagnosis of systemic autoimmune diseases. However, their correct interpretation is essential to avoid misdiagnoses, with particular... more

Redefining optimal medical therapy for heart failure in amyloid transthyretin cardiomyopathy

14 February 2026
Author(s): Alberto Aimo, Michele Emdin, Giuseppe Vergaro, Julian D Gillmore, Marianna Fontana

Amyloid transthyretin cardiomyopathy (ATTR-CM) is an infiltrative cardiomyopathy and an underdiagnosed cause of heart failure (HF) across the left ventricular ejection fraction spectrum. As disease-... more

Omics medicine: what the clinicians should know

10 February 2026
Author(s): Michela Gottardi Zamperla, Veronica Barbi, Sara Negri, Sandra Atlante, Carlo Gaetano

Omics technologies analyze comprehensive molecular datasets, enabling the detailed characterization of pathological processes. Genomic, transcriptomic, proteomic, and metabolomic approaches, as well... more

Chronic obstructive pulmonary disease (COPD) and cardiovascular comorbidities: Shedding light on key interactions and therapeutic approaches

6 February 2026
Author(s): Giulia M. Stella, Francesco R. Bertuccio, Valentina Conio, Chandra Bortolotto, Ilaria Salzillo, Edoardo Destefanis Gallo, Vito D’Agnano, Fabio Perrotta, Alice Maccarini, Angelo G. Corsico, Simone Savastano, Antonio Bozzani

Chronic obstructive pulmonary disease (COPD) is often associated with cardiovascular disease and the both conditions share common risk factors (smoke), associated pathophysiological mechanisms (... more

Precision medicine with pioneering RNAi therapeutics in ATTR amyloidosis: from bench to bedside

1 February 2026
Author(s): Silvia Malinverni, Giuseppe Vergaro, Guglielmo Verona, Aldostefano Porcari

Transthyretin (ATTR) amyloidosis is a multisystem disease caused by misfolding and aggregation of the plasma protein transthyretin (TTR) into insoluble amyloid fibrils in various organs [1]. This... more

Detecting dementia symptoms in internal medicine settings: clinical red flags, frailty and intervention perspectives

7 January 2026
Author(s): Cira Fundarò, Marina Maffoni

This paper provides a comprehensive overview of dementia in internal medicine hospital settings, highlighting its clinical detection, key red flags and frailty factors, as well as intervention... more

The evolving landscape of screening, management and treatment strategies of aortic stenosis in ATTR amyloidosis

28 November 2025
Author(s): Aldostefano Porcari, Matteo Serenelli, Rossana Bussani, Gianfranco Sinagra, Lucia Venneri

Transthyretin amyloid cardiomyopathy (ATTR-CM) and aortic stenosis (AS) frequently coexist in elderly patients, particularly men, creating a complex clinical scenario with overlapping symptoms and... more

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.